-
January 6, 2023 Math Over Myth: ATAI & Cathie Wood’s Reverse Midas TouchThis morning, ATAI Life Sciences (Nasdaq: ATAI) experienced a shocking drop of nearly 40% in...
-
September 9, 2022 Math Over Myth: Spotlight on Psychedelic Stocks ATAI & COMPASSIf you want to invest in psychedelic stocks, ignore the hype and look at the...
-
May 17, 2022 Comparing MindMed, Atai Life Sciences, Compass Pathways: A Psychedelic Stock AnalysisOur resident psychedelic investor explains a handful of important metrics to study when analyzing and...
-
May 10, 2022 Why Wednesday Will Be Biggest Day of 2022 for Psychedelic InvestorsPsychedelic investors are about to see pivotal data presented on flagship programs by the titans...
-
April 21, 2022 Kevin O’Leary Predicts These 3 Psychedelic Companies Will Merge, But Should They?Our resident Psychedelic Investor James Hallifax wonders if the "Shark Tank" star's prediction makes financial...
-
March 10, 2022 My Favorite Psychedelic Stocks: Part 1Our resident Psychedelic Investor details five companies he thinks are in strong position to win...
-
February 18, 2022 Psychedelic Business Spotlight – February 18This week in psychedelic business news: Nova Mentis makes progress on autism; atai donates to...
-
February 10, 2022 Cathie Wood’s ARK Genomic Revolution ETF Buys Psychedelic StockOur resident Psychedelic Investor explains why this is an important moment for the psychedelics sector.
-
February 4, 2022 4 Tips for Investing in Psychedelic Stocks During a Market DownturnFriendly advice for responsibly managing speculative bets on psychedelic stocks that may rise like a...
-
January 28, 2022 Psychedelic Business Spotlight — January 28This week in psychedelic business news: A major player begins manufacturing; another rebrands; and one...
